New RSV vaccines can be powerful tools, but rollout poses test
BioPharma Dive,
New vaccines for respiratory syncytial virus offer a significant opportunity this fall for protection against a pervasive…
New vaccines for respiratory syncytial virus offer a significant opportunity this fall for protection against a pervasive…
First published on Listen to the article 13 min This audio is auto-generated. Please let us know if you have feedback.
Demoradas por la pandemia de COVID-19, las vacunas contra el virus sincicial respiratorio (RSV), causante de la bronquiolitis…
Dive Brief: Sanofi and AstraZeneca released new study results on Friday that showed their antibody drug for respiratory…